The effect of nitric oxide on the production of prostaglandin E2 by hydroxyapatite-stimulated a human osteoblast (HOS) cell line

Biomedicine and Pharmacotherapy

Volumn 60, Issue 4, 2006, Pages 147-151

  Sugiatno, Erwan ^a,c   Samsudin, Abd Rani ^a   Ibrahim, M Fikri ^a   Sosroseno, Wihaskoro ^a,b  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Hydroxyapatite; Nitric oxide; Osteoblast; PGE2

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; ACETYLSALICYLIC ACID; ALPHA5 INTEGRIN; ANTIBODY; CD51 ANTIGEN; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYAPATITE; INDOMETACIN; N5 (1 IMINOETHYL)ORNITHINE; NIMESULIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROSO ACETYL PENICILLAMINE; PROSTAGLANDIN E2; S NITROSO ACETYL PENICILLAMINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; ENZYME INHIBITOR; N ACETYL S NITROSOPENICILLAMINE; N(G) IMINOETHYLORNITHINE; N(G)-IMINOETHYLORNITHINE; ORNITHINE;

ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SPECIFICITY; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; SURFACE PROPERTY; CELL LINE; METABOLISM;

CELL LINE; DINOPROSTONE; DURAPATITE; ENZYME INHIBITORS; HUMANS; INTEGRIN ALPHAV; NITRIC OXIDE; NITRIC OXIDE DONORS; ORNITHINE; OSTEOBLASTS; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 33745005927     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.02.008     Document Type: Article

References (30)

1. 2-biosynthetic pathway. Prog. Lipid Res. 43 (2004) 3-35
2. Suzawa T., Miyaura C., Inada M., Maruyama T., Sugimoto Y., Ushikubo F., et al. The role of prostaglandin E receptor subtypes (EP1. EP2, Ep3, and EP4) in bone resorption: an analysis using specific agonist for the respective EPs. Endocrinology 141 (2000) 1554-1559
3. 2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts. J. Cell. Biochem. 73 (1999) 36-48
4. 2 in osteoblastic cell lines and adult rat bone tissue. Bone 28 (2001) 275-281
5. 2 in osteoblasts by wall-shear stress but not mechanical strain. Am. J. Physiol. 273 (1997) E751-E758
6. 2 by primary bone cells is shear stress dependent. J. Biomech. 34 (2001) 671-677
7. Van't Hof R.J., and Ralston S.H. Nitric oxide and bone. Immunology 103 (2001) 255-261
8. 2. Eur. J. Pharmacol. 391 (2000) 225-231
9. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphate. Clin Orthopead Related Res 395 (2002) 81-98
10. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials 21 (2000) 667-681
11. Siebers M.C., Ter Grugge P.J., Walboomers X.F., and Jansen J.A. Integrins as linker proteins between osteoblasts and bone replacing materials. A critical review. Biomaterials 26 (2005) 137-146
12. Uemura T., Nemoto A., Liu Y.-K., Kojima H., Dong J., Yabe T., et al. Osteopontin involvement in bone remodeling and its effects on in vivo osteogenic potential of bone marrow-derived osteoblasts/porous hydroxyapatite construct. Mater. Sci. Eng. C 17 (2001) 33-36
13. Sun J.S., Tsuang Y.H., Liao C.J., Liu H.C., Hang Y.S., and Lin F.H. The effects of calcium phosphate particles on the growth of osteoblasts. J. Biomed. Mater. Res. 37 (1997) 324-334
14. Bigi A., Bracci B., Cuisinier F., Elkaim R., Fini M., Mayer I., et al. Human osteoblast response to pulsed laser deposited calcium phosphate coating. Biomaterials 26 (2005) 2381-2389
15. Akaike T., Yoshida M., Miyamoto Y., Sato K., Kohno M., Sasamoto K., et al. Antagonistic action of imidazolineoxyl N-oxides against endothelium- derived relaxing factor/NO through a radical reaction. Biochemistry 32 (1993) 827-832
16. Maeda H., Akaike T., Yoshida M., and Suga M. Multiple functions of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger. J. Leukoc. Biol. 56 (1994) 588-592
17. Corbett J.A., Kwon G., Turk J., and McDaniel M. IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islet of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32 (1993) 13767-13770
18. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90 (1993) 7240-7244
19. Kanematsu M., Ikeda Y., and Yamada Y. Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells. J. Bone Miner. Res. 12 (1997) 1789-1796
20. 2 release in MC3T3-E1 osteoblasts. J. Appl. Physiol. 97 (2004) 135-142
21. Matsuura T., Hosokawa R., Okamoto K., Kimoto T., and Akagawa Y. Diverse mechanisms of osteoblast spreading on hydroxyapatite and titanium. Biomaterials 21 (2000) 1121-1127
22. Park S.W., Lee S.G., Song S.H., Heo D.S., Park B.J., Lee D.W., Kim K.H., and Sung M.W. The effct of nitric oxide on cyoxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int. J. Cancer 107 (2003) 729-738
23. Diaz-Cazorla M., and Perez-Sala D. lamas S. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. J. Am. Soc. Nephrol. 10 (1999) 943-952
24. 2 biosynthesis in macrophages. J. Leukoc. Biol. 65 (1999) 792-799
25. Wittenberg J.M., Wittenberg R.H., and Osborn J.F. Prostaglandin release from rat femurs after implantation of hydroxylapatite and aluminum oxide ceramics. Prostaglandins Leukot. Essent. Fatty Acids 53 (1995) 413-417
26. Jiranek W.A., Machado M., Jasty M., Jevsevar J.D., Wolfe H., Goldring S.R., et al. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical technique and in situ hybridization. J Bone Jt Surg Am 75 (1993) 863-879
27. Perry M.J., Mortuza F.Y., Ponsford F.M., Elson C.J., Atkins R.M., and Learmonth I.D. Properties of tissue from around cemented joint implants with erosive and/or linear osteolysis. Bone 20 (1997) 521-526
28. Watkins S.C., Macaulay W., Turner D., Kang R., Rubash H.E., and Evans C.H. Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip protheses. Am. J. Pathol. 150 (1997) 1199-1206
29. Stea S., Visentin M., Donati M.E., Granchi D., Ciapetti G., Sudanese A., et al. Nitric oxide synthase in tissues around failed hip protheses. Biomaterials 23 (2002) 4833-4838
30. Chatelet J.C., and Setiey L. Long term bone behavior in total primary hip arthroplasty with a fully hydroxyapatite-coated femoral stem: a continuous series of 120 cases with twelve years follow-up. Rev. Chir. Orthop. Reparatrice Appar. Mot. 90 (2004) 628-635